Literature DB >> 582739

A newly developed precise and sensitive radioimmunoassay for clonidine.

D Arndts, H Stähle, C J Struck.   

Abstract

A new precise and sensitive radioimmunoassay for clonidine has been developed. Synthesis and analysis of the hapten (4-carboxy-clonidine; St 1984) as well as antibody production in rabbits are described in detail. At a final dilution of 1:1000 the resulting immune serum binds 50% of a tritiated clonidine standard containing 1 ng of clonidine. The detection limit of the presented radioimmunoassay for clonidine is 0.1 ng/ml. The coefficient of variation did not exceed 4.3% for any of 7 standard determinations with 5 replicates. There was no relevant cross-reactivity of inactive clonidine metabolites apart from 4-OH-clonidine. To avoid any errors from cross-reaction clonidine was selectively and quantitatively extracted into diethylether from unknown plasma samples. Following concentration of the extracts even such low concentrations as 20 pg of clonidine/ml plasma were detectable. With the radioimmunoassay applied in pharmacokinetic studies a maximal clonidine concentration in blood plasma of healthy human volunteers was determined to 0.6 ng/ml 1.5 h after oral administration of 150 micrograms.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 582739

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  6 in total

1.  Hyperadrenergic state following acute withdrawal from clonidine used at supratherapeutic doses.

Authors:  N J Sarlis; O Caticha; J L Anderson; C Kablitz; F S Shihab
Journal:  Clin Auton Res       Date:  1996-04       Impact factor: 4.435

2.  The Fourth Lilly Prize Lecture, University of Aberdeen, September 1980. The clinical pharmacology of clonidine and related central antihypertensive agents.

Authors:  J L Reid
Journal:  Br J Clin Pharmacol       Date:  1981-09       Impact factor: 4.335

3.  Relationship between plasma concentrations of clonidine and mean arterial pressure during an accidental clonidine overdose.

Authors:  L E Domino; S E Domino; M S Stockstill
Journal:  Br J Clin Pharmacol       Date:  1986-01       Impact factor: 4.335

Review 4.  Clinical pharmacokinetics of clonidine.

Authors:  D T Lowenthal; K M Matzek; T R MacGregor
Journal:  Clin Pharmacokinet       Date:  1988-05       Impact factor: 6.447

5.  Clonidine pharmacokinetics in pregnancy.

Authors:  M L Buchanan; T R Easterling; D B Carr; D D Shen; L J Risler; W L Nelson; D R Mattison; M F Hebert
Journal:  Drug Metab Dispos       Date:  2008-12-30       Impact factor: 3.922

6.  Pharmacokinetics and metabolism of 14C-labelled alinidine in man and dogs.

Authors:  D Arndts; G Leb; H J Förster
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1981       Impact factor: 2.441

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.